Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07744958
What this trial is testing

RESTORE-BLADDER (REgistry on STrategies for Organ pREservation in Muscle-invasive BLADDER Cancer)

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Heinrich-Heine University, Duesseldorf 100
Testing effectiveness (Phase 2)Study completedNCT02500121
What this trial is testing

Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer

Who this might be right for
Urothelial CarcinomaBladder Cancer
Matthew Galsky 108
Early research (Phase 1)Active Not RecruitingNCT05843448
What this trial is testing

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Who this might be right for
High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of California, Davis 6
Testing effectiveness (Phase 2)Looking for participantsNCT06511648
What this trial is testing

Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations

Who this might be right for
Muscle-invasive Bladder Cancer
Spanish Oncology Genito-Urinary Group 90
Not applicableLooking for participantsNCT04892849
What this trial is testing

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

Who this might be right for
HNSCCNSCLCEsophageal Cancer+4 more
University of Erlangen-Nürnberg Medical School 200
Not applicableUnknownNCT04588168
What this trial is testing

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

Who this might be right for
Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)Ended earlyNCT02887248
What this trial is testing

Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaBladder CancerTransitional Cell Carcinoma
SCRI Development Innovations, LLC 3
Testing effectiveness (Phase 2)Study completedNCT03159143
What this trial is testing

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Who this might be right for
Metastatic Transitional Cell Cancer of the Urothelial Tract
Leonard Appleman 22
Not applicableWithdrawnNCT02108587
What this trial is testing

Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer

Who this might be right for
Kidney/Urinary Cancer
Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT06863844
What this trial is testing

The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor

Who this might be right for
Urothelial Neoplasm
IRCCS Azienda Ospedaliero-Universitaria di Bologna 210
Testing effectiveness (Phase 2)Study completedNCT00661609
What this trial is testing

A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Bladder CancerUrethra Cancer+2 more
AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT01191892
What this trial is testing

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUreter Cancer+1 more
Cardiff University 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Not applicableEnded earlyNCT05568407
What this trial is testing

Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer

Who this might be right for
Bladder Cancer
Pfizer 19
Early research (Phase 1)Study completedNCT02903914
What this trial is testing

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorsColorectal Cancer (CRC)+7 more
Incyte Corporation 260
Large-scale testing (Phase 3)Active Not RecruitingNCT05092958
What this trial is testing

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

Who this might be right for
Advanced Bladder Urothelial CarcinomaAdvanced Renal Pelvis Urothelial CarcinomaAdvanced Ureter Urothelial Carcinoma+15 more
National Cancer Institute (NCI) 654
Not applicableUnknownNCT05139134
What this trial is testing

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

Who this might be right for
Urinary Bladder Urothelial Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)Study completedNCT01261728
What this trial is testing

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT05879822
What this trial is testing

Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

Who this might be right for
Advanced Solid Tumor
Incyte Corporation 73
Early research (Phase 1)Ended earlyNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 154
Next Page